Clinical trials continue to make stunning breakthroughs in treating diseases, especially those that remained uncurable for generations. One recent example making the rounds on the internet is Leqembi, which received FDA approval to treat early-stage Alzheimer’s disease. The drug’s clinical trials recorded a 27% decrease in the rate of cognitive decline throughout 18 months. These […]









